ALLMedicine™ Vasculitis Center

Nov 22nd, 2020 - To study the impact of glucocorticoid maintenance dose and treatment duration on outcomes in patients with AAV (ANCA-associated vasculitis) with emphasis on infectious complications. A total of 130 AAV patients from two German vasculitis centers d...

Nov 21st, 2020 - The clinical features of the kidney involvement in immunoglobulin A (IgA) vasculitis (IgAVN) differ in children and adults for both clinical presentation and progression. IgAVN in children has mostly a self-limiting course and favorable resolution...

Nov 20th, 2020 - The use of high-quality antigen-specific immunoassays for detecting anti-neutrophil cytoplasmic antibodies (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies is recommended in patients with suspected ANCA vasculitis and/or anti-GBM ...

Nov 20th, 2020 - Glomerular involvement in rheumatoid arthritis has been known to be associated with treatment side effects from medications and secondary amyloidosis. However, limited basic science and clinical studies have been performed to address the potential...

Nov 19th, 2020 - Durvalumab is a selective, high-affinity human immunoglobulin monoclonal antibody in a class called check point inhibitors, that blocks PD-L1 on tumour cells. Despite clinical success in increasing progression-free survival rates in patients with ...

Jan 20th, 2020 - JCS 2017 Guideline on Management of Vasculitis Syndrome　- Digest Version.|2020|Isobe M,Amano K,Arimura Y,Ishizu A,Ito S,|standards,standards,standards,diagnosis,epidemiology,physiopathology,therapy,

Jul 4th, 2019 - Since the publication of the European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV) in 2009, several relevant randomised clinical trials and cohort analyses have been published, which have th...

Mar 17th, 2019 - IgA vasculitis (IgAV, formerly known as Henoch-Schönlein purpura) is the most common cause of systemic vasculitis in childhood. To date, there are no internationally agreed, evidence-based guidelines concerning the appropriate diagnosis and treatm...

Oct 6th, 2017 - The proposal by the 1994 International Chapel Hill Consensus Conference on the Nomenclature of Systemic Vasculitides (CHCC1994) and by the CHCC2012 markedly influenced the classification and way of considering cutaneous vasculitis. In the proposal...

Mar 30th, 2017 - Kawasaki disease is an acute vasculitis of childhood that leads to coronary artery aneurysms in ≈25% of untreated cases. It has been reported worldwide and is the leading cause of acquired heart disease in children in developed countries. To revis...

Nov 22nd, 2020 - To study the impact of glucocorticoid maintenance dose and treatment duration on outcomes in patients with AAV (ANCA-associated vasculitis) with emphasis on infectious complications. A total of 130 AAV patients from two German vasculitis centers d...

Nov 21st, 2020 - The clinical features of the kidney involvement in immunoglobulin A (IgA) vasculitis (IgAVN) differ in children and adults for both clinical presentation and progression. IgAVN in children has mostly a self-limiting course and favorable resolution...

Nov 20th, 2020 - The use of high-quality antigen-specific immunoassays for detecting anti-neutrophil cytoplasmic antibodies (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies is recommended in patients with suspected ANCA vasculitis and/or anti-GBM ...

Nov 20th, 2020 - Glomerular involvement in rheumatoid arthritis has been known to be associated with treatment side effects from medications and secondary amyloidosis. However, limited basic science and clinical studies have been performed to address the potential...

Nov 19th, 2020 - Durvalumab is a selective, high-affinity human immunoglobulin monoclonal antibody in a class called check point inhibitors, that blocks PD-L1 on tumour cells. Despite clinical success in increasing progression-free survival rates in patients with ...

Sep 21st, 2020 - A new study has found that late-onset neutropenia is a notably common and occasionally serious occurrence in rituximab-treated patients with autoimmune diseases. "The literature on late-onset neutropenia – or LON – has, to date, been limited in si...

Jun 15th, 2020 - The US Food and Drug Administration (FDA) approved a label update for brolucizumab (Beovu, Novartis) that will include additional safety information regarding retinal vasculitis and retinal vascular occlusion after receiving postmarketing reports ...

May 27th, 2020 - This article was last updated on May 28, 2020. (Disclaimer: The information in this quiz may not be updated regularly. Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.) Kawasaki disease, also known as "mucocuta...

May 27th, 2020 - This article was last updated on May 28, 2020. (Disclaimer: The information in this quiz may not be updated regularly. Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.) Kawasaki disease, also known as "mucocuta...

Mar 5th, 2020 - IgA Vasculitis Presentation IgA vasculitis, or Henoch-Schönlein purpura, classically presents as a tetrad of palpable purpura, acute-onset arthritis or arthralgia, abdominal pain, and renal disease with proteinuria or hematuria. 30 Skin involvement.